Publication | Closed Access
Clinical and Molecular Studies of the Effect of Imatinib on Advanced Aggressive Fibromatosis (desmoid tumor)
315
Citations
28
References
2006
Year
Imatinib is an active agent in the treatment of advanced AF. Imatinib response in AF patients may be mediated by inhibition of PDGFRB kinase activity.
| Year | Citations | |
|---|---|---|
Page 1
Page 1